---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-011774"
form_type: "8-K"
ticker: "RFL"
cik: "0001713863"
company_name: "Rafael Holdings, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:13:25.111044+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Rafael Holdings and Cyclo Therapeutics extend merger deadline to March 31, 2025

## Summary
- Amendment No. 2 to Merger Agreement extends the End Date from February 15, 2025 to March 31, 2025.
- Rafael Holdings holds approximately 39.5% of Cyclo Therapeutics' outstanding common stock.
- Extension allows additional time for SEC to declare the Form S-4 registration statement effective.

## SEC filing metadata
- accession: 0001213900-25-011774
- form_type: 8-K
- ticker: RFL
- cik: 0001713863
- company_name: Rafael Holdings, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1713863/000121390025011774/0001213900-25-011774-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1713863/000121390025011774/ea0230532-8k_rafael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-011774
- JSON: https://secwatch.observer/filing/0001213900-25-011774.json
- Plain text: https://secwatch.observer/filing/0001213900-25-011774.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.